Monica Mann Reflects on a Life Dedicated to Healthcare Transformation
BioMarin Pharmaceutical· Original source
🌍Industryorchestrabiomed.com
Strengthening AVIM Therapy’s Regulatory Pathway: A Second FDA Breakthrough Device Designation
Orchestra BioMed· Original source
🇺🇸Industrynews.abbvie.com
Allergan Aesthetics Launches Philanthropic Effort in Recognition of Skin Cancer Awareness Month
AbbVie News· Original source
🇺🇸Industrybioreference.com
BioReference® Launches BioReference Direct™, Expanding Access to Consumer-Initiated Diagnostic Testing Through a Fully Integrated Digital Platform
BioReference Laboratories· Original source
🇮🇹Industryrecordati.com
Media – RECORDATI: SUMMARY REPORT OF THE VOTES – ORDINARY AND EXTRAORDINARY GENERAL MEETING OF THE SHAREHOLDERS 29.04.2026
Recordati· Original source
🌍Industryaptose.com
Aptose Biosciences Announces Update on Anticipated Timing of Closing of the Plan of Arrangement with Hanmi Pharmaceutical
Aptose Biosciences· Original source
🇺🇸Industrybristolmyers2016ir.q4web.com
Bristol Myers Squibb Reports First Quarter Financial Results for 2026
Bristol-Myers Squibb News· Original source
🇺🇸Industryinvestor.lilly.com
Lilly reports first-quarter 2026 financial results, raises full year guidance, and highlights momentum of new medicines
Eli Lilly News· Original source
🇺🇸Industrymerck.com
Merck & Co., Inc., Rahway, N.J., USA Announces First-Quarter 2026 Financial Results; Highlights Significant Regulatory Approvals and Clinical Milestones
Merck & Co. (MSD) News· Original source
🇮🇹Industryrecordati.com
MEDIA – Press release (on “il Sole 24 Ore”) – 2025 final payment dividend
Recordati· Original source
🇨🇭Industryroche.com
Roche to present extensive data showcasing its industry-leading ophthalmology portfolio at ARVO 2026
Roche Newsroom· Original source
🇯🇵Industryotsuka.co.jp
Otsuka Launches "Educational Materials and Resources by Otsuka" for Educators to Support Health Education in Schools Providing Free Digital Health Education Materials on Heat Illness Prevention and Nutrition Education
Otsuka Pharmaceutical· Original source
🇺🇸Industrybiomarin.com
Tommaso Corio Discusses His Journey from BioMarin Internship to International Impact
BioMarin Pharmaceutical· Original source
🇨🇦Industryir.beonemedicines.com
U.S. FDA Grants Priority Review to BeOne Medicines’ TEVIMBRA in First-Line HER2+ GEA
Zymeworks· Original source
🌍Industryadial.com
Adial Pharmaceuticals Advances IP Portfolio with New U.S. Utility Patent Application, Positioning for Potential Market Exclusivity Through 2045
Adial Pharmaceuticals· Original source
🇺🇸Industryir.codexis.com
Codexis to share RNA manufacturing advances at TIDES USA
RECORDATI: THE SHAREHOLDERS’ MEETING APPROVES THE 2025 FINANCIAL STATEMENTS AND THE DIVIDEND OF €1.34 PER SHARE (+5.5% VS. 2024). NEW BOARD OF STATUTORY AUDITORS APPOINTED
Recordati· Original source
🇬🇧Industrygsk.com
GSK delivers strong Q1 performance and start to 2026
GSK News· Original source
🌍Industryrss.globenewswire.com
GH Research Announces Pricing of $117.5 Million Underwritten Offering
GH Research· Original source
🇺🇸Industryir.unither.com
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
United Therapeutics (IR)· Original source
🇨🇦Industryir.bauschhealth.com
Bausch Health Announces First Quarter 2026 Results
Bausch Health (IR News)· Original source
🌍Industryeledon.com
We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment
Eledon Pharmaceuticals· Original source
🌍Industryorchestrabiomed.com
From Blood Pressure Reduction to Cardiac Function: What New AVIM Therapy Data Signal
Orchestra BioMed· Original source
🇬🇧Industrygsk.com
Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA
GSK News· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
AbbVie News· Original source
🌍Industrybenitec.com
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Benitec Biopharma· Original source
🇺🇸Industrymerck.com
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
Merck & Co. (MSD) News· Original source
🇪🇸Industryrovi.es
Cuidar de las personas, construir prevención
Laboratorios Rovi· Original source
🇯🇵Industrytaiho.co.jp
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Otsuka Holdings RSS· Original source
🇯🇵Industrytaiho.co.jp
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
Adial Pharmaceuticals· Original source
🇨🇦Industryinvestor.jazzpharma.com
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Zymeworks· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
AbbVie News· Original source
🇬🇧Industrygsk.com
GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH
GSK News· Original source
🌍Industrycormedix.com
CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE III RESPECT TRIAL ASSESSING REZZAYO® FOR THE PROPHYLAXIS OF INVASIVE FUNGAL DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS
CorMedix· Original source
🌍Industrynervgen.com
NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer
NervGen Pharma· Original source
🇺🇸Industryinvestor.lilly.com
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
Eli Lilly News· Original source
🇬🇧Industrygsk.com
TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation
GSK News· Original source
🇯🇵Industrynewsroom.astellas.com
Financial Results of Astellas for FY2025
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Notice Regarding Impairment Loss and Extraordinary Losses in Non-consolidated Financial Results(J-GAAP)
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Notice of Nominees for Directors
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Astellas Announces Personnel Change
Astellas Pharma· Original source
🇯🇵Industrysumitomo-pharma.com
Notice regarding Withdrawal of Shelf Registration Statement for Issuance of New Shares
Sumitomo Pharma· Original source
🇯🇵Industrynippon-shinyaku.co.jp
日本新薬アドバンス主催「ふれあいまつり」を開催
Nippon Shinyaku News· Original source
🇺🇸Industrybristolmyers2016ir.q4web.com
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
Bristol-Myers Squibb News· Original source
🇺🇸Industrymerck.com
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
Merck & Co. (MSD) News· Original source
🇯🇵Industrychugai-pharm.co.jp
2026年12月期第1四半期連結決算
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
Chugai Announces 2026 1st Quarter Results
Chugai Pharmaceutical· Original source
🇯🇵Industrychugai-pharm.co.jp
組織改正・人事のお知らせ
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
Organizational and Personnel Changes
Chugai Pharmaceutical· Original source
🇯🇵Industrychugai-pharm.co.jp
信託型株式報酬制度の導入に伴う株式取得の詳細決定に関するお知らせ
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
Determination of Details Regarding Share Acquisition Associated with the Introduction of the Trust-Based Stock Compensation System
Chugai Pharmaceutical· Original source
🇯🇵Industrynewsroom.astellas.com
Astellas Amends Settlement and License Agreement with MSN regarding Myrbetriq®
Astellas Pharma· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Provides Update on TrenibotulinumtoxinE (TrenibotE) Biologics License Application in the U.S.
AbbVie News· Original source
🇺🇸Industryir.codexis.com
Codexis to Report First Quarter 2026 Financial Results on May 7
Codexis· Original source
🇧🇪Industrypharma.be
Dierproeven: verminderen, verfijnen, vervangen
pharma.be Belgium· Original source
🇧🇪Industrypharma.be
Van cijfers naar keuzes: hoe houden we de innovatiespiraal draaiende?
pharma.be Belgium· Original source
🇧🇪Industrypharma.be
Wereldvaccinatieweek 2026: ouderen willen zich laten vaccineren, maar missen een duidelijk vaccinatiebeleid
pharma.be Belgium· Original source
🌍Industrymonashhealth.org
Changes to pathology results from Sunday, 3 May
Monash Health· Original source
🇨🇭Industryroche.com
[Ad hoc announcement pursuant to Art. 53 LR] Roche reports strong sales growth of +6% at constant exchange rates in the first quarter of 2026; -5% in CHF due to the significant appreciation of the Swiss franc
Roche Newsroom· Original source
🇫🇷Industryipsen.com
Strong Q1 2026 sales growth, marking a solid start to the year
Ipsen· Original source
🇯🇵Industrychugai-pharm.co.jp
エフ・ホフマン・ラ・ロシュの2026年第1四半期の販売実績について
Chugai Pharmaceutical News· Original source
🇯🇵Industrychugai-pharm.co.jp
F. Hoffmann-La Roche Announces First Quarter Sales 2026
Chugai Pharmaceutical· Original source
🇺🇸Industrycsafeglobal.com
CSafe Advanced Parcel Data Sheet
CSafe Global· Original source
🇺🇸Industrythefdalawblog.com
What Does DOJ’s New Corporate Enforcement Policy Mean for the FDA- and DEA-Regulated Industry?
Hyman, Phelps & McNamara (FDA Law)· Original source
🌍Industrywuxibiologics.com
WuXi Biologics Receives South Korea MFDS GMP Certification to Enable Commercial Manufacturing of Bispecific Antibody Therapeutics
WuXi Biologics· Original source
🇯🇵Industryrecormedical.com
Recor Medical's Paradise Ultrasound Renal Denervation System Honored with TAG Award for Cardiovascular Therapeutic Innovation (Link to Recor website)
Otsuka Holdings RSS· Original source
🌍Industrywuxibiologics.com
Monthly Biologics News & Articles | WuXi Biologics | April
WuXi Biologics· Original source
🇺🇸Industrycertara.com
ADC Dose Optimization: Applying Model-Informed Strategies in Development
Certara· Original source
🇧🇷Industryems.com.br
Com patrocínio da EMS, “Shrek – O Musical” chega ao Teatro Renault em São Paulo
EMS Pharma News· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Selects North Carolina for New $1.4 Billion Manufacturing Campus
AbbVie News· Original source
🇮🇹Industryrecordati.com
RECORDATI: THE SHAREHOLDERS’ MEETING APPROVES THE 2025 FINANCIAL STATEMENTS AND THE DIVIDEND OF €1.34 PER SHARE (+5.5% VS. 2024). NEW BOARD OF STATUTORY AUDITORS APPOINTED
Recordati· Original source
🇬🇧Industrygsk.com
GSK delivers strong Q1 performance and start to 2026
GSK News· Original source
🌍Industryrss.globenewswire.com
GH Research Announces Pricing of $117.5 Million Underwritten Offering
GH Research· Original source
🇺🇸Industryir.unither.com
United Therapeutics Corporation Announces Retirement of Professor Raymond Dwek, C.B.E., F.R.S., From Its Board of Directors
United Therapeutics (IR)· Original source
🇨🇦Industryir.bauschhealth.com
Bausch Health Announces First Quarter 2026 Results
Bausch Health (IR News)· Original source
🌍Industryeledon.com
We fact-checked the hype behind the Eledon Pharmaceuticals Type 1 diabetes treatment
Eledon Pharmaceuticals· Original source
🌍Industryorchestrabiomed.com
From Blood Pressure Reduction to Cardiac Function: What New AVIM Therapy Data Signal
Orchestra BioMed· Original source
🇬🇧Industrygsk.com
Bepirovirsen accepted for priority review and granted Breakthrough Therapy Designation by the US FDA
GSK News· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Submits Application to FDA for Upadacitinib (RINVOQ®) for Adults and Adolescents with Severe Alopecia Areata
AbbVie News· Original source
🌍Industrybenitec.com
Benitec Biopharma Announces Oral Presentation of Interim Phase 1b/2a Clinical Study Results for High Dose BB-301 and Continued Durable Improvements for Low Dose BB-301 at the 2026 American Society of Gene and Cell Therapy Annual Meeting
Benitec Biopharma· Original source
🇺🇸Industrymerck.com
Merck’s Playing with Heart Program Teams Up With Professional Baseball Clubs and Baseball Legends to Help Raise Awareness About LDL-C, Called “Bad” Cholesterol, and How It May Impact the Risk of Heart Attack or Stroke
Merck & Co. (MSD) News· Original source
🇪🇸Industryrovi.es
Cuidar de las personas, construir prevención
Laboratorios Rovi· Original source
🇯🇵Industrytaiho.co.jp
U.S. Food and Drug Administration Accepts New Drug Application for Zipalertinib for the Treatment of Locally Advanced or Metastatic Non-Small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations
Otsuka Holdings RSS· Original source
🇯🇵Industrytaiho.co.jp
Taiho Oncology, Taiho Pharmaceutical and Araris Biotech AG Advance ADC ARC-02 into Phase 1 Clinical Development
Adial Pharmaceuticals Submits Application to FDA Commissioner’s National Priority Voucher (CNPV) Pilot Program for AD04 Clinical Development Program
Adial Pharmaceuticals· Original source
🇨🇦Industryinvestor.jazzpharma.com
Jazz Pharmaceuticals Announces FDA Acceptance and Priority Review of Supplemental Biologics License Application for Ziihera® (zanidatamab-hrii) Combinations in First-Line HER2+ Locally Advanced or Metastatic GEA
Zymeworks· Original source
🇺🇸Industrynews.abbvie.com
AbbVie Submits Regulatory Application to FDA for SKYRIZI® (risankizumab-rzaa) Subcutaneous Induction for Adults with Moderately to Severely Active Crohn's Disease
AbbVie News· Original source
🇬🇧Industrygsk.com
GSK’s investigational liver therapy, efimosfermin, receives US FDA Breakthrough Therapy and EMA Priority Medicines (PRIME) designations for MASH
GSK News· Original source
🌍Industrycormedix.com
CORMEDIX THERAPEUTICS ANNOUNCES POSITIVE TOPLINE RESULTS FROM PHASE III RESPECT TRIAL ASSESSING REZZAYO® FOR THE PROPHYLAXIS OF INVASIVE FUNGAL DISEASES IN ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION PATIENTS
CorMedix· Original source
🌍Industrynervgen.com
NervGen Pharma Strengthens Leadership Team with Appointment of Keith Vendola as Chief Financial Officer
NervGen Pharma· Original source
🇺🇸Industryinvestor.lilly.com
Lilly to acquire Ajax Therapeutics to advance outcomes for patients with myelofibrosis and polycythemia vera
Eli Lilly News· Original source
🇬🇧Industrygsk.com
TESARO, a GSK subsidiary, provides update on AnaptysBio, Inc. litigation
GSK News· Original source
🇯🇵Industrynewsroom.astellas.com
Financial Results of Astellas for FY2025
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Notice Regarding Impairment Loss and Extraordinary Losses in Non-consolidated Financial Results(J-GAAP)
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Notice of Nominees for Directors
Astellas Pharma· Original source
🇯🇵Industrynewsroom.astellas.com
Astellas Announces Personnel Change
Astellas Pharma· Original source
🇯🇵Industrysumitomo-pharma.com
Notice regarding Withdrawal of Shelf Registration Statement for Issuance of New Shares
Sumitomo Pharma· Original source
🇯🇵Industrynippon-shinyaku.co.jp
日本新薬アドバンス主催「ふれあいまつり」を開催
Nippon Shinyaku News· Original source
🇺🇸Industrybristolmyers2016ir.q4web.com
Bristol Myers Squibb and Pfizer to Make Eliquis® (apixaban) Available via Mark Cuban Cost Plus Drug Company
Bristol-Myers Squibb News· Original source
🇺🇸Industrymerck.com
Merck Announces Expiration of Hart-Scott-Rodino Act Waiting Period to Acquire Terns Pharmaceuticals, Inc.
